Genetic aspects of variability in superficial vein responsiveness to norepinephrine

Venoconstriction of the dorsal hand vein by local norepinephrine infusion was measured by the linear variable differential transformer method in 15 healthy unrelated subjects and eight pairs of monozygotic and six pairs of dizygotic twins. Incremental norepinephrine infusion produced dose‐related venoconstriction. In unrelated subjects the doses of norepinephrine constricting basal vein diameter by 50% (ED 50 ) ranged from 3.9 to 120.5 ng/min. There was a positive linear relationship between doses of norepinephrine infused and local steady‐state plasma concentrations of norepinephrine achieved in each subject. The reciprocals of the slopes of these dose‐concentration relationships, which reflect local norepinephrine clearance (disposition) in the vein, ranged from 0.47 to 1.86 ml/min. Plasma concentrations of norepinephrine associated with reduction of basal vein diameter by 50% (EC 50 ) ranged from 1.4 to 110.2 ng/ml, with variability similar to that of ED 50 . There was a very high level of concordance in ED 50 , EC 50 , and clearance of norepinephrine within pairs of monozygotic twins but not within dizygotic twins. Differences in pharmacokinetics of infused norepinephrine exert a minor impact on overall intersubject variability. Genetic aspects of “tissue responsiveness” (i.e., vascular a‐adrenoceptor response, smooth muscle contractility, and endothelial function) appear to be largely responsible for the wide intersubject variability in venoconstrictor responsiveness to norepinephrine. Clinical Pharmacology and Therapeutics (1991) 49, 355–361; doi: 10.1038/clpt.1991.41